Nasdaq
$0.2795▼ 0.89%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $636,804.97Shares out 2.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 4d agoPre-market26.10.21 22:23DEF 14COther#●●●#●●●
Propanc Biopharma, Inc.
Propanc Biopharma has approved a reverse stock split of its common stock at a ratio between 1:2 and 1:10 via board and majority shareholder written consent. The action is intended to maintain the company's financing and capital-raising capabilities, reducing the 10,331,116 shares outstanding as of October 8, 2026, to between approximately 5,165,558 and 1,033,112 shares.…more
$0.2795-0.89%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8After-hours26.10.09 06:25PRE 14COther
Propanc Biopharma, Inc.
Propanc Biopharma has approved a reverse stock split of its common stock at a ratio between 1:2 and 1:10, authorized by the Board and majority shareholders. The action is intended to maintain the company's financing and capital-raising capabilities, reducing the 10,331,116 shares outstanding as of October 8, 2026, to between approximately 5,165,558 and 1,033,112 shares.…more
$0.2795-0.89%vs prev closeView filingShare - 10.5After-hours26.10.06 06:15S-1Offering
Propanc Biopharma, Inc.
Propanc Biopharma has filed an S-1 registration statement for the resale of 6,500,000 shares of common stock issuable upon the conversion of Series C Preferred Stock. This filing facilitates the conversion and potential resale of shares by the existing preferred stockholder.…more
$0.2795-0.89%vs prev closeView filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoAfter-hours26.10.23 05:24Bullish#●●●#●●●
Propanc Biopharma Implements 1-for-10 Reverse Stock Split to Maintain Nasdaq Listing…more
Propanc Biopharma is executing a 1-for-10 reverse stock split to meet Nasdaq's minimum bid price requirement and maintain its listing. The company states this action is intended to support future growth plans and upcoming R&D milestones.…more
$0.2795-0.89%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 3d agoPre-market26.10.22 21:30
●●●●●●●● ●●●●● ●●●●●●
Propanc Biopharma is executing a 1-for-10 reverse stock split to comply with Nasdaq's minimum bid price requirement and maintain its listing. This corporate action adjusts the share count without changing the company's fundamental valuation.…more
$0.2795-0.89%vs prev close - 10.16Pre-market26.10.16 21:36
●●●●●●●● ●●●●● ●●●●●●
Propanc Biopharma reported that its lead candidate, PRP, successfully reprogrammed chemotherapy-resistant pancreatic cancer cells to restore therapeutic sensitivity in preclinical studies. As these findings are based on early-stage research, further clinical validation is required to confirm therapeutic efficacy.…more
$0.2795-0.89%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report